Find out how ICT can support biomedical and clinical researchFind out more. From Clever cars to clever farms... Embedded Systems
NIPR

NIPR Pty Ltd is a wholly-owned, for-profit commercialisation and investment subsidiary of NICTA.

NIPR’s role is to commercialise NICTA's research by licensing NICTA IP and providing resources to help researchers start companies.

NIPR is the vehicle that allows commercial benefits from NICTA research to flow back to NICTA and its staff. NIPR is governed by a strict set of procedures and is overseen by a Board.

 

NICTA's Investment Model

Grants Pre-Commercialisation

Up to AUD 50K Market Development Grant Up to AUD 100K Proof of Concept
Investments for Commercialisation
Up to AUD 250K NIPR Investment
Up to further AUD 250K from NIPR


 

As at August 2007 NICTA had awarded:

  • Market Demand Grants: 9
  • Proof-of-Concept Grants: 5
  • Commercialisation Development Investment:3

NIPR is involved in all licensing transactions and ensures that these transactions result in a wide use of NICTA-developed IP.

For NICTA research groups hoping to convert their research into a spin-out company, NIPR offers a series of grants to refine and test their business plans. NIPR makes pre-seed investments in NICTA spin out companies that pass its rigorous evaluation process.